Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 29, 2026

Lockheed Martin (LMT) Q4 2025 Earnings Transcript

View original at finance.yahoo.com
Lockheed Martin (LMT) Q4 2025 Earnings Transcript Image source: The Motley Fool. DATE Thursday, January 29, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — James D…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Skunk Works expected to achieve double-digit growth in 2026

    80% confidence
  • Lockheed Martin has been striving to make up for F-35 sustainment underfunding with internal investment

    80% confidence
  • PAC-3 MSE framework definitization expected in 2026 following authorization through Congress

    80% confidence
  • F-35 sustainment has been historically underfunded for 4-5 years in spare parts and repair capacity

    80% confidence
  • Aeronautics classified program continues to have complex design risk over next few years but had no Q4 charges

    80% confidence
  • The PAC-3 MSE framework agreement is a groundbreaking step in bringing commercial business practices to large-scale production within the defense industrial base

    80% confidence
  • Lockheed Martin intends to make a multibillion-dollar investment to accelerate munition production over the next three years

    80% confidence
  • MFC business area expected to grow at double-digit CAGR through end of decade

    80% confidence
  • Lockheed Martin is all about disruptive technology

    80% confidence
  • 2025 marked unprecedented demand for Lockheed Martin's industry-leading defense technologies

    80% confidence
  • If any initiative doesn't have military theater-level scalability, it's interesting but will not be decisive

    80% confidence
  • Company publicly advocating for F-35 multiyear framework covering production, modernization, and sustainment with no impediment to similar structure as missile frameworks

    80% confidence
  • F-35 production rate is five times faster than any other allied fighter currently in production

    80% confidence
  • Space-Based Interceptor targeting operational flight by 2028

    80% confidence
  • Total investment (CapEx plus R&D) approaching $5 billion in 2026, +35% year-over-year

    80% confidence
  • 2026 pension requirement returns at approximately $1 billion minimum as 2026 was fully prefunded in 2025

    80% confidence
  • Backlog grew $17.3 billion, or 17%, and included significant awards for key programs

    80% confidence
  • Improving F-35 mission-capable rates is an absolute priority for Lockheed Martin

    80% confidence
  • F-35 sustainment expected to achieve potential double-digit growth in 2026

    80% confidence
  • The PAC-3 framework agreement represents a customer partnering to find the best, most efficient way to rapidly scale capabilities to the warfighter

    80% confidence

Data points we hold from this source

Lockheed Martin Corporation · segment operating profit6.7 billion_USD
Lockheed Martin Corporation · free cash flow6.9 billion_USD
Lockheed Martin Corporation · revenue75 billion_USD
Lockheed Martin Corporation · revenue20.3 billion_USD
Lockheed Martin Corporation · free cash flow2.8 billion_USD
Lockheed Martin Corporation · employee count121000 employees
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
Lockheed Martin (LMT) Q4 2025 Earnings Transcript — Source | Via News | ViaNews Market